The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary Cancers Symposium later this week in San Francisco, California. The new ...
Maximum tumor diameter (MTD) showed a strong association with the risk for relapse in patients with limited-stage Hodgkin lymphoma (HL) achieving PET negativity, with each centimeter increase in MTD ...
Real-world data shows a clear association between increased tumor size and mortality in brain cancer patients. Early diagnosis using Dxcover's PANAROMIC liquid biopsy platform can reduce mortality ...